Many laboratories are racing to improve treatments for nail infections, and one of the newest ideas emerging from European research circles involves a compound better known for its strong sulfur odor.
Teams at the University of Bath and King’s College London are working to develop a topical product that uses a controlled release of hydrogen sulfide, aiming for a formulation that can penetrate the nail more efficiently than the medications currently available.
A technology shaped by older chemistry
Sulfur-based substances have been explored in dermatology for decades. Historically they were used in ointments for skin conditions because of their antimicrobial effects, though the smell and irritation limited wider use.
The renewed interest comes from understanding how tiny sulfur molecules travel through dense biological material, including the nail plate.
This insight has led Bath and KCL researchers to revisit the chemistry with modern delivery systems, allowing low, safe concentrations to move deeply into the nail where infections take hold.
Also read: Experts outline health trends to reconsider in 2026
The hope is to produce a treatment that acts faster and is easier for patients to use consistently.
Why the condition is difficult to treat
Nail infections are among the most persistent dermatological problems. Nordic health registries report that 5–12% of adults experience fungal nail disease, with prevalence increasing sharply after the age of 60.
Dermatologists generally point to three reasons for the condition’s stubbornness:
– the nail’s rigid structure blocks many therapeutic agents
– treatment courses are long, often leading patients to stop early
– resistant fungal strains are becoming more common
These factors have contributed to low cure rates for many topical products, despite steady improvements in formulation technology.
What this approach could change
The new hydrogen sulfide–based method, detailed in Scientific Reports, suggests a route past the physical barrier of the nail.
Early laboratory work indicates that the compound may disrupt microbial energy systems, potentially offering a way to overcome resistance seen in standard antifungal treatments.
Although clinical use remains several years away, the research signals a shift toward more targeted and technologically sophisticated solutions for one of the most widespread minor infections worldwide.
Also read: New research: There is no single right diet for healthy aging
Sources: ScienceDaily and Nature
Also read: Bone health isn’t just about milk – these vegetables also contribute